Courtagen Life Sciences Blog

15 New Panels Address Ciliopathy, Endocrinology, Neuromuscular, Bone Density, and Connective Tissue

Disease Spotlight: Angelman Syndrome

11 New Spotlight™ Panels added to test menu

10 New Spotlight™ Panels for Targeted Genetic Testing

Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent

Diagnosing Hyperparathyroidism with Genetic Testing

New Spotlight Panels are Here!

Genetic Testing Helps Patient Beat 10 Year Battle with Seizures

Pathogenic, Benign, or Uncertain: Evaluating Genetic Variants

Autism, Intellectual Disability, or Both?

The Power of Parents: How Parent Samples Improve Genetic Testing Results

ALG13: X-Linked Gene Causes Severe Neurological Disease in Females

Is Cannabis a Reasonable Option for Treating Epilepsy?

How Courtagen's Genetic Tests Differ from 23andMe

We Have a New Home

4 Common Genetic Testing Myths Debunked

Mitochondrial disease patients face frustration when going to the Emergency Room

Diagnosing Mitochondrial Disease with Genetic Testing

Courtagen Partners with UMDF to Provide Complementary Genetic Testing for Mitochondrial disorders

5 Ways Genetic Testing Can Make a Difference

How Genetic Testing Helped Our Son

The Role of Genetic Testing in Diagnosing Autism Spectrum Disorder

Upcoming Webinar: The Role of Genetic Testing Panels in Clinical Practice

Sun, Surf, and Smiles at Venice Beach THERASurf Event

Benefits of Ordering Genetic Testing at the Beginning of the Diagnostic Process

Courtagen Featured in PBS News Hour's Medical Cannabis Story

Quick Case: Creatine Supplementation as Treatment for Seizure Disorder

Why Everyone with Epilepsy Should Get a Genetic Test